TG Therapeutics reported 75.56 in PE Price to Earnings for its fiscal quarter ending in September of 2026.





Pe Change Date
AbbVie 23.45 0.51 Sep/2026
Amgen 18.6 0.53 Sep/2026
Arrowhead Research 39.19 0 Jun/2026
Bayer 4.61 0.47 Sep/2026
Biogen 29.15 5.92 Sep/2026
Corcept Therapeutics 86.2 102.04 Sep/2026
Gilead Sciences 17.68 4.18 Sep/2026
J&J 25.86 3.57 Sep/2026
Novartis 19.17 3.24 Sep/2026
Novavax 2.01 1.07 Dec/2025
PTC Therapeutics 8.76 0 Jun/2026
Puma Biotechnology 13.93 44.88 Jun/2024
Regeneron Pharmaceuticals 15.46 9.68 Jun/2026
Roche Holding 16.48 0.39 Jun/2026
TG Therapeutics 75.56 55.92 Sep/2026
Vertex Pharmaceuticals 29.35 1.3 Sep/2026